Atlas Trials

Follow-up of the Persistence of the Complete Molecular Remission After Stopping Imatinib Chronic Myeloid Leukemia

Clinical trial NCT02896829 · COMPLETED

Trial details

NCT number
NCT02896829
Sponsor
University Hospital, Bordeaux
Status
COMPLETED
Study type
OBSERVATIONAL
Chronic Myeloid Leukemia
Start date
2013-04-03
Primary completion
2019-04-01
Enrollment
97

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.